| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 11.89M | — |
| Operating expense | — | — |
| Net income | -18.23M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 8EM.F returned +4.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +46.7% |
| 1 year | +4.7% |
| 5 years | -95.3% |
| 10 years | -83.1% |
| All-time high | €62.60 (Dec 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 8EM.F would be worth today ›No. Editas Medicine, Inc. has not paid a dividend in the past 12 months.
Editas Medicine, Inc. is part of the Healthcare sector.
Editas Medicine, Inc. has a market cap of 390.09M EUR, based on the latest quote.
